Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcatheter Treatment of Tricuspid Valve Regurgitation With the TriFlo Tricuspid Flow Optimizer (TFO) System

NCT06093828 is registered in ClinicalTrials.gov with TriFlo Cardiovascular, Inc. as lead sponsor.

NCT NCT06093828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06093828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcatheter Treatment of Tricuspid Valve Regurgitation With the TriFlo Tricuspid Flow Optimizer (TFO) System
Lead sponsor
TriFlo Cardiovascular, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
December 31, 2031
Enrollment
40 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic severe tricuspid regurgitation